A Japanese patient with a 2p25.3 terminal deletion presented with early-onset obesity, intellectual disability and diabetes mellitus: A case report.


Journal

Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702

Informations de publication

Date de publication:
Feb 2022
Historique:
revised: 04 08 2021
received: 31 05 2021
accepted: 06 08 2021
pubmed: 13 8 2021
medline: 19 2 2022
entrez: 12 8 2021
Statut: ppublish

Résumé

2p25.3 deletion syndrome is a rare genetic disorder that accompanies various phenotypic features, including early-onset obesity and intellectual disability. Here, we report the first Japanese case of this deletion associated with severe obesity and diabetes mellitus. Microarray-based comparative genomic hybridization analysis identified a 3.1-Mb deletion of distal chromosome band 2p25.3, which was suspected as de novo. The patient also presented bilateral cataracts and adolescent-onset muscular weakness of the upper limbs, both of which were uncommon in previously reported cases. It is possible that these symptoms are also important clinical features suggestive of this syndrome.

Identifiants

pubmed: 34382350
doi: 10.1111/jdi.13645
pmc: PMC8847130
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

391-396

Informations de copyright

© 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Références

Eur J Hum Genet. 2014 Apr;22(4):471-9
pubmed: 24129437
Am J Hum Genet. 2011 Sep 9;89(3):464-73
pubmed: 21907015
PLoS Genet. 2017 Aug 31;13(8):e1006957
pubmed: 28859103
Genet Med. 2015 Jun;17(6):460-6
pubmed: 25232846
Am J Med Genet A. 2017 May;173(5):1264-1269
pubmed: 28371282
Am J Med Genet A. 2011 Nov;155A(11):2739-45
pubmed: 21990140
Obes Rev. 2008 Mar;9 Suppl 1:53-61
pubmed: 18307700
Hum Mol Genet. 2014 Nov 1;23(21):5597-614
pubmed: 24895407
Am J Med Genet A. 2020 May;182(5):1021-1031
pubmed: 32065501
Sci Rep. 2018 Apr 24;8(1):6451
pubmed: 29691431

Auteurs

Taka-Aki Sakaue (TA)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Yoshinari Obata (Y)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Yuya Fujishima (Y)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Junji Kozawa (J)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
Department of Diabetes Care Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Michio Otsuki (M)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Toshiyuki Yamamoto (T)

Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.

Norikazu Maeda (N)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.
Department of Metabolism and Atherosclerosis, Graduate School of Medicine Osaka University, Osaka, Japan.

Hitoshi Nishizawa (H)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Iichiro Shimomura (I)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH